Related Experiment Video
Updated: Jan 14, 2026

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
Published on: December 1, 2023
Neurocognitive and Behavioral Outcomes in Patients With Insulin Resistance and Type 2 Diabetes: A Systematic Review
Aqsa Ahmed1, Zulfiqar Ali2, Momina Abid3
1Medicine and Surgery, Medicare Hospital, Faisalabad, PAK.
Abstract:
This systematic review explores the association between insulin resistance (IR) and type 2 diabetes (T2D) with neurocognitive and behavioral outcomes in adolescents. With the rising global burden of metabolic disorders in youth, understanding the cognitive implications is crucial. A comprehensive search was conducted across PubMed, Scopus, and Web of Science, yielding 665 records. Following stringent eligibility criteria and quality screening, nine studies published between January 2020 and June 2024 were included. These studies assessed executive function, memory, attention, emotional regulation, and neuroimaging outcomes in adolescents aged 10-19 years with IR or T2D. Most studies (seven of nine) demonstrated either a low risk of bias (RoB) or some concerns, with none rated as high risk. The findings consistently pointed to impairments in executive functioning, working memory, and psychosocial outcomes, with eight of nine studies (89%) reporting at least one cognitive or behavioral deficit. However, heterogeneity in outcome measures and study designs limited direct comparability. The review highlights emerging evidence of a diabetes-cognition link during adolescence, emphasizing the need for early interventions and standardized cognitive assessments. Gaps remain in long-term follow-up, representation from low- and middle-income countries (LMICs), and the exploration of modifiable lifestyle factors. This review adds to the growing call for targeted research and public health strategies to address the neurocognitive vulnerabilities associated with adolescent metabolic dysfunction.
More Related Videos
06:21Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
Published on: April 7, 2023
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes: Symptoms, Diagnosis, and Complications
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...